Venom anaphylaxis - immunotherapy pharmalgen (TA246)
Fast, easy summary view of NICE guidance on 'anaphylaxis'
NICE recommends Pharmalgen as a possible treatment for some people with bee or wasp venom allergy (see below).
Who can have Pharmalgen?
You should be able to have Pharmalgen if:
- you have had a severe reaction to a bee or wasp sting, or
- you have had a moderate reaction to a bee or wasp sting and you have one or more of the following: a high risk of stings, anxiety about stings, raised levels of a protein called ‘tryptase’ in your blood.
Why has NICE said this?
NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS. NICE recommended Pharmalgen because, although it costs more than other treatments, this was justified by the benefits it provided.
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: anaphylaxis
- None found
This page was last updated: 27 June 2012
- Web format
- Full Guidance (PDF)
- TA246 Pharmalgen ar gyfer trin alergedd i wenwyn gwenyn a chacwn: deall canllawiau NICE (fformat MS Word)
Information for the public
Implementation tools and resources
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.